Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Last day of trading in warrants of series TO 1 is 30 August 2022

Tuesday, 30 August 2022, is the last day of trading in CS MEDICA A/S’s (“CS MEDICA” or the “Company”) warrants of series TO 1 on Spotlight Stock Market. The warrants were issued in connection with the Company’s issue of units that took place in September 2021. Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in CS MEDICA. Last day to exercise the warrants of series TO 1 and subscribe for shares is 1 September 2022. Note that the banks/nominees need to be notified well in advance before the exercise period ends.Each (1) warrant of series TO 1 entitles

I-Tech AB (publ) Interim report Q2 2022

I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2022 Click here on the 26 August 2022 at 10:30 to follow the webcast  Click here to go to I-Tech's Financial Reports Summary of the period ” Record strong sales with increased profitability ” •    Net turnover for the first quarter amounted to 17 654 (12 819) kSEK, corresponding to an increase in turnover of 38% (-21%). Operating profit/loss amounted to 1 469 (-3 192) kSEK. April to June 2022 •

Q2 2022 Interim financial report

FINANCIAL HIGHLIGHTS  · Group revenue of SEK 248.3m (SEK 214.8m). · Gross profit margin 40.7% (38.5%). · EBITDA of SEK 28.5m (SEK 20.3m). · Nonrecurring items of SEK 2.4m related to cost program. · Adjusted EBITDA of SEK 30.9m (SEK 20.3m) · Net operating cash flow SEK 9.7m (SEK 5.1m). · Cost reduction program, Robust 22, finalized with estimated full year effect of appr. SEK 30m. · Freight prices and raw material prices still on high levels. · Delays in deliveries from several suppliers. · Order intake was SEK 294.7m (SEK 266.9m), and order backlog of SEK

Safello Publishes Interim Report for Q2 2022

Stockholm, 26 August 2022 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the second quarter (1 April-30 June) 2022. The report can be found on safello.com/ir . The quarter was characterized by a high level of activity in regard to executed orders, despite turbulence in the market. “Safello now serves more than 2.5% of Sweden’s population. During the second quarter, we took action to trim the organization and ensure that we operate more

Flexion signs second agreement with tap4fun

LONDON, 26 August 2022 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company has signed an agreement with tap4fun to publish Kiss of War on the alternative app stores. Flexion will distribute the hit game on the ONE store, Amazon and Samsung Galaxy app stores in Q4 2022. Kiss of War is the second game Flexion has launched for tap4fun, having published Kingdom Guard on the alternative app stores in April 2022. This is testament to the increased revenue and audiences tap4fun is seeing thanks to Flexion. “We’re delighted tap4fun has chosen to work with Flexion

The share-based long-term incentive scheme of the key employees of Stockmann plc and its subsidiaries

STOCKMANN plc, Other information disclosed according to the rules of the Exchange 26.8.2022 at 9:00 EET   The Board of Directors of Stockmann plc (the "Company") has decided on the establishment of the share-based long-term incentive scheme targeted to the management and selected key personnel of the Company and its subsidiaries (jointly the “Group”). The incentive scheme consists of a Performance Share Plan (also “PSP”).   The objectives of the Performance Share Plan are to support the implementation of the Company’s strategy, to align the interests of the key personnel with

Glycorex Transplantation AB (GTAB B): Interim report January-June 2022

Accelerating sales growth“Glycorex had a strong second quarter of 2022 with solid double-digit growth. Demand grew as the effects of the COVID-19-pandemic continued to subside which, combined with an effective implementation of the company’s G4G strategy, delivered a very good quarter.”  – Geert Nygaard, CEO Financial information April – June 2022 · Net sales: SEK 11.2 million (8.0) · Operating income: SEK -1.7 million (-2.2) · Net income for the period: SEK -1.7 million (-2.3) · Earnings per share: SEK -0.02 (-0.03) Events in the second quarter · Distributor

Interim report April - June 2022

Quant releases the interim report for April - June 2022.April-June · Net sales for the quarter improved to EUR 43.6 (40.5) million. Organically, net sales increased by 6.0% · During the quarter the contract portfolio value increased by net EUR 12.0 million. One contract was won, four contracts were renewed, and two contracts were lost. Portfolio run rate annualized net sales at the end of the quarter was EUR 188.8 million, compared to EUR 176.8 million at the end of the first quarter of 2022 · Operating loss for the quarter improved compared to prior year and amounted to EUR -0.2

ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2022

GROWTH DESPITE GREAT UNCERTAINTY IN THE WORLD Revenues during the second quarter of 2022 amounted to SEK 329.5 (322.4) million, which corresponded to 2% (18%) growth compared to the corresponding period last year. The EBITDA result amounted to SEK 20.1 (33.4) million and the EBITDA margin to 6.1% (10.4%). This demonstrated that the company managed to maintain high sales levels combined with profitability despite the influence of external factors. Sharply rising commodity and transportation prices, sales-suppressing shutdowns in the APAC region, and effects of the Russia-Ukraine war made

InDex Pharmaceuticals Holding AB (publ) interim report January – June 2022

PMDA supports InDex’s development plan for cobitolimod in Japan“With great interest from the clinics for our phase III study CONCLUDE and cobitolimod, our successful interactions with the Japanese regulatory authority PMDA, as well as with a strengthened patent portfolio, InDex is strongly equipped for cobitolimod’s path towards market approval”, says Johan Giléus, acting CEO of InDex Pharmaceuticals. Period April – June 2022 · Net sales amounted to SEK 0.0 (0.0) million · Operating loss amounted to SEK –21.7 (–42.6) million · Result after tax amounted to SEK –21.7 (–42.6)

Karo Pharma Aktiebolag comments on the public offer from Karo Intressenter AB and obtains a fairness opinion

Background On 16 August 2022, Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma") to acquire the shares in Karo Pharma not already held by Karo Intressenter (the "Offer") at a price of SEK 60 per share (the "Consideration"). As of the date of this press release, Karo Intressenter holds 236,720,058 shares in Karo Pharma, corresponding to 86.6 per cent of the share capital and votes in Karo Pharma. Hence, Karo Intressenter is the parent company of Karo Pharma. The acceptance period for the Offer

SAS Q3 2022 report

INCREASED DEMAND AND PROGRESS WITH SAS FORWARD BUT QUARTER IS NEGATIVELY IMPACTED BY OPERATIONAL RAMP-UP CHALLENGES AND PILOT STRIKESAS results were severely affected by a 15-day pilot strike between July 4 and July 19, causing traffic disruption and leading to some 4,000 canceled flights affecting more than 380,000 passengers. I sincerely apologize to our customers and partners who were affected by the traffic disruptions.   Overall underlying demand for travel was healthy during the summer quarter and SAS noted an increasing number of passengers eager to travel as restrictions were

United Bankers Plc’s Half-Year Financial Report 1 Jan – 30 June 2022: Positive performance in a difficult market environment – real estate and forest funds supported the company’s profit growth

United Bankers Plc STOCK EXCHANGE RELEASE 26 August 2022 at 09:00 EEST   United Bankers Plc’s Half-Year Financial Report 1 Jan – 30 June 2022: Positive performance in a difficult market environment – real estate and forest funds supported the company’s profit growth   This stock exchange release is a summary of the United Bankers’ Half-Year Financial Report 1 Jan – 30 June 2022. The complete Half-Year Financial Report with tables is attached to this release and is also available on the Company’s website at www.unitedbankers.fi .

Everfuel signs MoU with Karlstads Energi for establishing a hydrogen hub

Herning, Denmark, 26 August 2022 – Everfuel A/S is pleased to announce the signing of a Memorandum of Understanding (MoU) with Karlstads Energi for a collaboration on developing a hydrogen hub in Karlstad, Sweden. The two parties plan to explore the commercial and technical feasibility of constructing a 20 MW electrolysis facility as a first phase of the hub development. The facility is intended to produce green hydrogen, supply excess heat to the local district heating owned and operated by Karlstads Energi, utilise the produced oxygen for industry purposes and supply green fuel to both

Rikshem’s interim report January – June 2022: Strong financial position and continued high investment pace

Rikshem remains stable in a market that has undergone rapid change. The company increased its rental income by 3.2 percent during the period, while continuing to maintain a high rate of investment in properties at MSEK 1,249 (774). Net operating income is unchanged from the same period last year at MSEK 867 (867), despite rising energy prices.“I can confirm that we stand firm despite the uncertainty around us. We have good liquidity, good bank connections and a good rating. At the start of the summer, Moody’s confirmed the long-term credit rating of A3 with stable outlook. Rikshem has a

Interim report January–June 2022 Nordax Bank AB

Highlights January–June 2022 · Total lending amounted to SEK 78.7 billion (SEK 70.7 billion as of 31 December 2021) · Personal loans and credit cards amounted to SEK 64.3 billion (SEK 58.0 billion as of 31 December 2021) · Mortgage lending (mortgage loans and equity release mortgages) amounted to SEK 14.4 billion (SEK 12.7 billion as of 31 December 2021), comprising 18% of total lending · Nordax’s savings offering continued to grow and total deposits amounts to SEK 70.6 billion (SEK 67.4 billion as of 31 December 2021) · Operating profit amounted to SEK 659 million (430),

Interim report January–June 2022 Nordax Holding AB

Highlights January–June 2022 · Total lending amounted to SEK 79.4 billion (SEK 71.4 billion as of 31 December 2021) · Personal loans and credit cards amounted to SEK 65.0 billion (SEK 58.7 billion as of 31 December 2021) · Mortgage lending (mortgage loans and equity release mortgages) amounted to SEK 14.4 billion (SEK 12.7 billion as of 31 December 2021), comprising 18% of total lending · Nordax’s savings offering continued to grow and total deposits amounts to SEK 70.6 billion (SEK 67.4 billion as of 31 December 2021) · Operating profit amounted to SEK 591 million (362),

DSRT: Desert Control releases its Q2 2022 Report and Interim Financial Results

ISSUER DESERT CONTROL AS Sandnes, Norway, 26 August 2022Desert Control today published Q2 2022 Report and Interim Financial Results.The Q2 report and the presentation are attached and can also be found via theCompany’s website: https://www.desertcontrol.com/investorsCommercial activities commenced in the UAE. The company progressed ahead ofexpectations in the United States and continued to deliver on commitments in thesecond quarter.Q2 and H1 2022 HighlightsCommercial activities commenced in the UAE:- The first commercial deliveries commenced in the UAE end of June

Spinnova Plc: Spinnova’s General Counsel Lasse Holopainen appointed to the management team

SPINNOVA PLC, COMPANY RELEASE, 26 August 2022 at 8:00 a.m. EEST Spinnova Plc: Spinnova’s General Counsel Lasse Holopainen appointed to the management team General Counsel and Board Secretary Lasse Holopainen has been appointed a member of the Spinnova management team as of 1 September 2022.                As General Counsel, Lasse has been responsible for all legal matters of the company and advising senior management on legal and compliance related topics. As Board Secretary, he supports and advises Spinnova’s Board of Directors and its committees in their work. Lasse will

Aros Bostad’s interim report for January - June 2022 shows significantly increased operating profit and high sales ratio in ongoing projects

Aros Bostadsutveckling AB publ (”Aros Bostad”) delivers an interim report for January to June 2022 showing significantly increased operating profit and additional projects for own development. During the quarter, the divestment of a large portfolio with project properties was completed - corresponding to 878 rental apartments for a sales price of SEK 3.6 billion – which contributes to a ratio of 91 percent sold or booked apartments in ongoing projects. Furthermore, the agreement regarding a structural deal with ALM Equity was announced, which adds 34 new project opportunities.Magnus

Billion-kroner contract to Rosenberg Worley

Aker BP and alliance partner Aker Solutions are awarding Rosenberg Worley a letter of intent for the construction of two modules for the new central platform on the Valhall field in the North Sea. This contract represents the largest new-build project in many years, and it will lead to 1,000 jobs at Rosenberg in Stavanger. "With this award, Aker BP and Aker Solutions are ensuring additional ongoing activity in Norway, in a project that falls under the temporary tax changes. The choice of a Norwegian yard is entirely deliberate. It demonstrates that we're responding to the politicians'

Greenfood’s interim report second quarter 2022

The second quarter of the year was characterised by a focus on execution, with increased business traction for Picadeli, Greenfood’s high-tech, sustainable salad concept. Summary of period 1 April – 30 June · Net sales for the period totalled SEK 1,391.6 million (1,117.3) an increase of 24.5%. · Adjusted EBITDA improved significantly with SEK 18.9 million to SEK 69.5 million (50.6) compared with the second quarter 2021. · Operating profit/loss amounted to SEK 4.4 million (7.9) including non-recurring items of SEK -3.8 million (-0.1) and expenses from unestablished businesses

Borr Drilling Limited – 2022 Annual General Meeting

Borr Drilling Limited (NYSE and OSE: BORR) advises that its 2022 Annual General Meeting will be held on September 30, 2022. The record date for voting at the Annual General Meeting is set to September 6, 2022. The notice, agenda and associated material will be distributed prior to the meeting. Hamilton, Bermuda August 25, 2022 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Nordea Bank Abp: Repurchase of own shares on 25.08.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares25.08.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 25.08.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 250,000 9.56 2,389,275.00CEUX 330,965 9.56 3,165,028.82TQEX 0 - 0.00  XSTO 250,000 9.57  2,392,767.42XCSE

There are no items matching the current filter
There are no more items matching the current filter
Back to top